Subscribe
The Food and Drug Administration has issued new guidance on blood donations, removing some long-standing deferrals. In addition to this, the FDA is also considering moving towards an individualized risk-based approach when deciding donor eligibility. These changes are related to HIV medications and those at risk for contracting HIV.
Pictured: The text “Updates to FDA Blood Donor Deferrals Coming Soon,” is shown across an image of an arm giving blood, with DHA and ASBP logos shown in the bottom corners.
| Date Taken: | 06.02.2023 |
| Date Posted: | 06.05.2023 09:05 |
| Photo ID: | 7832508 |
| VIRIN: | 230602-O-MM018-418 |
| Resolution: | 1200x800 |
| Size: | 565.91 KB |
| Location: | US |
| Web Views: | 18 |
| Downloads: | 2 |
This work, New FDA Guidance for Long-standing Deferral; HIV Changes, by Jonathan Davis, identified by DVIDS, must comply with the restrictions shown on https://www.dvidshub.net/about/copyright.
